# Variant Bio: Research, Seattle, United States

> Variant Bio: Variant Bio is a biotechnology company based in Seattle, founded in 2018. Based in Seattle, United States. Founded 2018.

Source: https://millionrounds.com/startup/variant-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Variant Bio

Variant Bio is a biotechnology company based in Seattle, founded in 2018.

Funding reported Last round: Series B

Research Seattle, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 38 11 to 50 people
- **Funding reported:** $130M in dollars
- **Last round:** Series B Nov 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Variant Bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Variant Bio

Variant Bio is a biotechnology company based in Seattle, founded in 2018.

The company focuses on developing life-saving therapies by studying the genes of individuals with exceptional health-related traits. It aims to enhance genomic drug discovery by leveraging human genetic diversity to understand diseases better and improve clinical trial outcomes. The company offers a range of services in genomic research, including sequencing technology, phenotyping, statistical genetics, and machine learning. Variant Bio emphasizes ethical research collaborations, particularly with underrepresented populations, ensuring that these communities benefit from the research. Its proprietary Genomic Database includes data from over 20 global populations, enhancing the understanding of genetic diversity. Variant Bio's key product is the Inference platform, an AI-driven genomic drug discovery tool that analyzes genetic data to identify new drug candidates. The company maintains a therapeutic pipeline targeting conditions such as fibrosis, kidney disease, and metabolic disorders. It collaborates with pharmaceutical and biotech partners to improve drug development success rates, while also engaging with historically underrepresented communities to ensure equitable benefits from its research initiatives.

## What company datasets say Variant Bio raised

Funding, as reported

Reported in all **$130M** in dollars

Rounds **2**

Last round **Series B**

Last round size **$105M**

Last round date **Nov 2021**

Investors listed **8**

## Founders and team

From Variant Bio's own website and the SEC filings it signed: 3 on the team.

- **Andrew Farnum** Chief Executive Officer
- **Holly Vance** Chief Operating Officer
- **Stephane Castel** Executive Officer, Director i

On the board, as filed i *Bob More* *Elena Viboch* *Josh Wolfe* *Julie Sunderland* *Stuart Nagae*

## On a portfolio page

Investors who name them

- [Alta Partners](https://millionrounds.com/fund/alta-partners)

Each firm lists Variant Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

genomic partnerships benefit sharing health care genetic targets biotechnology research information technology & services genomic research ethical genomics hospital & health care medical therapeutic development health biotechnology multi-omic data services drug development

Built with from their website

Jira Service Management WordPress.org Atlassian Flow Google Workspace CloudFlare Viewport Meta Atlassian Confluence Apple Quest KACE Systems Deployment Appliance

+8 more

AWS Analytics Apple Business Manager Google Meet NVivo Act! Bunny BASE SEOmatic

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** Washington
- **Revenue:** $3.0M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/variant-bio)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Variant Bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)